90 likes | 166 Views
Get more details @ http://bit.ly/2oBj4cQ <br>Few players dominate clinical nutrition market such as Abbott Laboratories, Nestle, Danone, Fresenius Kabi, Hospira, Perrigo, B Braun Melsungen, Baxter International and Mead Johnson. Product development, strategic alliances and consolidating across the distribution channel remain key commercial strategies adopted by industry participants. Industry participants are also expanding their operations in emerging economies to gain extended market access and strengthen their market position.
E N D
Global Clinical Nutrition Market to surpass $80 billion by 2024: Fractovia.org Fuel Cell Market size worth $25.5bn by 2024
Key Insights ofClinical Nutrition Market: • The growing geriatric population, rise in the number of metabolic disorders, and an increase in the number of premature births are key factors that will propel clinical nutrition market, which was worth USD 40 billion in 2015, and will grow at a CAGR of 7% over 2017-2024. • The world is witnessing a rise in the number of disorders subject to the lack of proper nutrition, as per scientists. • Clinical nutrition market is controlled by a specific number of leading players accounting for a major share. • Pertaining to the growth of clinical nutritional market in India and China, APAC is likely to experience a massive growth over the years ahead. • Infant products accounted for more than 55% of clinical nutrition market in 2015, and is likely to grow at a CAGR of 9% over 2017-2024. • Milk based infant products contributed to more than 70% of infant clinical nutrition industy share in 2015, and will cross a revenue of more than USD 35 billion by 2024, subject to the rising inclination toward tasty, tolerant, healthy milk-based nutritional products for toddlers.
Continued… • Parenteral nutritional products are fairly prominent in the product landscape of clinical nutrition market, having held a valuation of more than USD 4.2 billion in 2015. • Amino acids accounted for more than 40% of parenteral clinical nutrition market share in 2015 and will grow substantially over 2017-2024, subject to the fact that they effectively help address the body metabolism issues. • In 2015, U.S. clinical nutrition market size was worth more than USD 8 billion, and will grow at a rate of 6% over 2017-2024. • In 2015, UK accounted for more than 17% of Europe clinical nutrition market share, subject to the increasing disposable incomes of patients and the rising expenditure on healthcare. • Companies such as Hospira, Baxter International, Danone, B Braun Melsungen, Nestle, Mead Johnson, Perrigo, Fresenius Kabi, Abbott Laboratories, and H. J. Heinz mainly operate in this industry, and are engaged in tried-and-tested as well as innovative growth strategies to expand their business and provide a competitive edge to their rivals.
Europe Clinical Nutrition Market, By Product, 2012 - 2024 (USD Million)
Browse Full Market Research Report of Clinical Nutrition Market @ http://bit.ly/2q1grC7 Request for a Sample of this Research report @ https://www.fractovia.org/request-sample/469
Table of Contents: Chapter 1. Methodology & Scope 1.1 Research Methodology 1.1.1 Initial data exploration 1.1.2 Statistical model and forecast 1.1.3 Industry insights and validation 1.1.4 Market definition and forecast parameters 1.2 Data Sources 1.2.1 Primary 1.2.2 Secondary Chapter 2. Executive Summary 2.1 Clinical Nutrition industry 3600 synopsis, 2012 - 2024 2.1.1 Business trends 2.1.2 Product trends 2.1.3 Regional trends Chapter 3. Clinical Nutrition Industry Insights 3.1 Industry segmentation 3.2 Industry size & forecast, 2012 - 2024 3.3 Industry ecosystem analysis 3.3.1 Distribution channel analysis 3.4 Industry impact forces
Continued… 3.4.1 Growth Drivers 3.4.1.1 Increasing metabolic disorders and other chronic diseases 3.4.1.2 Junk food habits leading to malnourishment in U.S. & Europe 3.4.1.3 Increasing geriatric population 3.4.1.4 Increasing rate of pre-mature birth & birth rate in APAC 3.4.1.5 Increasing adoption of home healthcare in North America and Europe 3.4.2 Industry pitfalls & Challenges 3.4.2.1 Stringent government regulations in U.S., Europe, and APAC 3.4.2.2 Lack of awareness regarding nutrition in developing countries 3.5 Growth potential analysis 3.6 Regulatory landscape 3.6.1 U.S. 3.6.2 Europe 3.6.3 China 3.7 Reimbursement scenario 3.7.1 U.S. 3.7.2 Europe 3.8 Pipeline analysis
Continued… 3.9 Pricing analysis 3.9.1 North America 3.9.2 Europe 3.9.3 Asia Pacific 3.9.4 Latin America 3.9.5 MEA 3.10 Volume analysis 3.10.1 North America 3.10.2 Europe 3.10.3 Asia-Pacific 3.10.4 Latin-America 3.10.5 Middle East & Africa 3.11 Patent Landscape 3.11.1 Infant nutrition 3.11.2 Enteral Nutrition 3.11.3 Parenteral nutrition 3.12 Porter's Analysis 3.13 PESTEL Analysis 3.14 Company market share analysis, 2016 3.14.1. Revenue 3.14.2. Product landscape 3.14.2. Strategic landscape
Stay In Touch Website: https://www.fractovia.org Social Media: